RPID 1.05 Stock Price Rapid Micro Biosystems, Inc.
Range: | 0.58-1.34 | Vol Avg: | 69995 | Last Div: | 0 | Changes: | 0.05 |
Beta: | 1.08 | Cap: | 0.05B | Currency: | USD | Exchange: | NASDAQ |
Sector: | Healthcare | IPO: | Thu Jul 15 2021 | Empoloyees: | 193 |
CUSIP: | 75340L104 | CIK: | 0001380106 | ISIN: | US75340L1044 | Country: | US |
CEO: | Mr. Robert G. Spignesi Jr. | Website: | https://www.rapidmicrobio.com |
Rapid Micro Biosystems, Inc., a life sciences technology company, provides products for the detection of microbial contamination in the manufacture of pharmaceutical, medical devices, and personal care products in North America, Europe, and Asia. The company offers Growth Direct platform, which includes Growth Direct system, proprietary consumables, lab information management system connection software, and comprehensive customer support and validation services. Its platform automates and modernizes the manual microbial quality control (MQC) testing workflows for therapeutic modalities, such as biologics, vaccines, cell and gene therapies, and sterile injectables. The company also provides installation and verification, technical training, and support services. Its solutions are used in environmental monitoring, water testing, bioburden, and sterility release testing applications. The company was formerly known as Genomic Profiling Systems, Inc. and changed its name to Rapid Micro Biosystems, Inc. in January 2007. Rapid Micro Biosystems, Inc. was incorporated in 2006 and is headquartered in Lowell, Massachusetts.
The content provided on this site is for informational purposes only and does not constitute financial, investment, or professional advice. We are not registered investment advisors or financial planners, and we do not provide recommendations or advice on buying, selling, or holding any particular stocks or securities. Any investment decisions should be made based on your own research and consultation with a qualified financial professional. We are not responsible for any financial loss or damages incurred from reliance on the information provided on this site. Please invest responsibly and seek professional advice when needed.